Unknown

Dataset Information

0

A chemical biology approach to identifying molecular pathways associated with aging.


ABSTRACT: The understanding of how aging contributes to dementia remains obscure. To address this problem, a chemical biology approach was used employing CAD031, an Alzheimer's disease (AD) drug candidate identified using a discovery platform based upon phenotypic screens that mimic toxicities associated with the aging brain. Since CAD031 has therapeutic efficacy when fed to old symptomatic transgenic AD mice, the chemical biology hypothesis is that it can be used to determine the molecular pathways associated with age-related disease by identifying those that are modified by the compound. Here we show that when CAD031 was fed to rapidly aging SAMP8 mice starting in the last quadrant of their lifespan, it reduced many of the changes in gene, protein, and small molecule expression associated with mitochondrial aging, maintaining mitochondria at the younger molecular phenotype. Network analysis integrating the metabolomics and transcription data followed by mechanistic validation showed that CAD031 targets acetyl-CoA and fatty acid metabolism via the AMPK/ACC1 pathway. Importantly, CAD031 extended the median lifespan of SAMP8 mice by about 30%. These data show that specific alterations in mitochondrial composition and metabolism highly correlate with aging, supporting the use AD drug candidates that limit physiological aging in the brain.

SUBMITTER: Currais A 

PROVIDER: S-EPMC8050149 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3043094 | biostudies-literature
| S-EPMC3070611 | biostudies-literature
| S-EPMC3866263 | biostudies-literature
| S-EPMC9404828 | biostudies-literature
| S-EPMC5271458 | biostudies-literature
| S-EPMC9691312 | biostudies-literature
| S-EPMC2629491 | biostudies-literature
| S-EPMC4667946 | biostudies-literature
| S-EPMC7145985 | biostudies-literature
| S-EPMC10085735 | biostudies-literature